SILVERCORP METALS INC (SVM)

CA82835P1036 - Common Stock

3.15  +0.15 (+5%)

After market: 3.15 0 (0%)


Fundamental Rating

4

Overall SVM gets a fundamental rating of 4 out of 10. We evaluated SVM against 950 industry peers in the Metals & Mining industry. While SVM has a great health rating, but there are worries on its profitability. SVM has a correct valuation and a medium growth rate.




Profitability

Profitability Rating

2

SVM has a Profit Margin of 11.29%. This is comparable to the industry average of 13.41%.
The Piotroski-F score of SVM is 6.00. This is a neutral score and indicates average health and profitability for SVM.

SVM has a Return On Assets of 3.57%. This is below the industry average of 7.46%.
SVM's Return On Equity of 5.00% is worse than the rest of the industry. The industry average Return On Equity is 11.87%.
VS Industry

ROA (3.57%) VS Industry: 25% outperformed.

0.08
97.16

ROE (5%) VS Industry: 24% outperformed.

0.15
143.82

Profit Margin (11.29%) VS Industry: 41% outperformed.

0.24
1,224.45

Valuation

Valuation Rating

4

Compared to an average industry price book ratio of 1.54, SVM is valued rather cheaply
Compared to an average Enterprise Value to EBITDA ratio of 6.23, SVM is valued rather cheaply. On top of this, SVM has a better ratio than 82% of the companies listed in the same industry.
With a Price/Earnings Ratio of 13.13, SVM is valued correctly.

Compared to an average industry Price/Earning Ratio of 14.00, SVM is valued in line with its industry peers.
The Forward Price/Earnings Ratio of 20.79 indicates a rather expensive current valuation of SVM.
When comparing the current price to the book value of SVM, we can conclude it is valued correctly. It is trading at 1.14 times its book value.
VS Industry

Price/Earnings (13.13) VS Industry: 52% outperformed.

469.50
0.10

Price/Book (1.14) VS Industry: 61% outperformed.

241.20
0.03

Enterprise Value/ EBITDA (3.19) VS Industry: 82% outperformed.

555.61
0.08

Growth

Growth Rating

4

Based on estimates for the next 5 years, SVM will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.30% on average per year.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Measured over the past 5 years, SVM shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.23% on average per year.
The Revenue has been growing slightly by 5.91% on average over the past 5 years.

SVM is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 6.61% yearly.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
SVM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.24%.
SVM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.42%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-7.23% 17.23% -17.24% -26.86% -27.72% -19.46% 14.3%
Revenue5.91% 8.52% -20.42% -2.95% -2.19% -2.74% 6.61%

Health

Health Rating

7

A Current Ratio of 4.77 indicates that SVM has no problem at all paying its short term obligations.
When comparing the Current Ratio to an average industry Current Ratio of 2.55, SVM is better placed than the average industry peer to meet its short term obligations.
A Quick Ratio of 4.61 indicates that SVM has no problem at all paying its short term obligations.
SVM is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.08.

SVM has an Altman-Z score of 3.12. This indicates that SVM is financially healthy and little risk of bankruptcy at the moment.
The Debt to Equity ratio of SVM is in line with the industry averages.
The Altman-Z score is in line with the industry averages, which is at 2.21.
SVM has a Piotroski-F score of 6.00. This indicates an average health and profitability for SVM.
VS Industry

Debt/Equity (0) VS Industry: 49% outperformed.

9.62
0.00

Quick Ratio (4.61) VS Industry: 67% outperformed.

0.00
178.59

Current Ratio (4.77) VS Industry: 67% outperformed.

0.00
178.59

Altman-Z (3.12) VS Industry: 55% outperformed.

-2,971.54
2,434.72

Dividend

Dividend Rating

4

On average, the dividend of SVM grows each year by 21.10%, which is quite nice.
18.18% of the earnings are spent on dividend by SVM. This is a low number and sustainable payout ratio.
SVM has been paying a dividend for over 5 years, so it has already some track record.
With a yearly dividend of 0.85%, SVM is not a good candidate for dividend investing.

With a Dividend Yield of 0.85, SVM pays less dividend than the industry average, which is at 2.31. 89% of the companies listed in the same industry pay a better dividend than SVM!
Compared to an average S&P500 Dividend Yield of 2.72, SVM's dividend is way lower than the S&P500 average.
SVM's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (0.85%) VS Industry: 11% outperformed.

0.24
27.57

SILVERCORP METALS INC

NYSEARCA:SVM (6/1/2023, 3:31:10 PM)

After market: 3.15 0 (0%)

3.15

+0.15 (+5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-25 2023-05-25/amc
Earnings (Next)08-09 2023-08-09/amc
Inst Owners24.52%
Inst Owner Change5.64%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap556.83M
Analysts85
Price Target4.67 (48.25%)
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Dividend Growth(5Y)21.1%
DP18.18%
Div Incr YearsN/A
Div Non Decr Years1
Ex-Date06-09 2023-06-09 (0.01)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.68%
Min EPS beat(2)-11.99%
Max EPS beat(2)6.63%
EPS beat(4)2
Avg EPS beat(4)0.86%
Min EPS beat(4)-11.99%
Max EPS beat(4)18.81%
Revenue beat(2)1
Avg Revenue beat(2)1.14%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)3.05%
Revenue beat(4)3
Avg Revenue beat(4)2%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)3.99%
PT rev (1m)1.96%
PT rev (3m)4.79%
EPS NQ rev (1m)33.33%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)-1.54%
Revenue NQ rev (3m)-6.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 13.13
Fwd PE 20.79
P/S 2.58
P/FCF 16.03
P/OCF 6.1
P/B 1.14
P/tB 1.14
EV/EBITDA 3.19
EPS(TTM)0.24
EY7.62%
EPS(NY)0.15
Fwd EY4.81%
FCF(TTM)0.2
FCFY6.24%
OCF(TTM)0.52
OCFY16.4%
SpS1.22
BVpS2.75
TBVpS2.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.57%
ROE 5%
ROIC 7.32%
ROICexc 10.96%
ROICexgc 10.96%
OM 27.24%
PM 11.29%
GM 40.93%
ROA(3y)6.01%
ROA(5y)7.17%
ROE(3y)8.4%
ROE(5y)10.18%
ROIC(3y)8.41%
ROIC(5y)9.52%
ROICexc(3y)12.22%
ROICexc(5y)13.24%
ROICexgc(3y)12.22%
ROICexgc(5y)13.24%
ROICexcg growth 3Y-5.16%
ROICexcg growth 5Y-10.85%
ROICexc growth 3Y-5.16%
ROICexc growth 5Y-10.85%
OM growth 3Y-4%
OM growth 5Y-5.56%
PM growth 3Y-15.48%
PM growth 5Y-12.06%
GM growth 3Y-2.57%
GM growth 5Y-3.5%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA 0.01
Cap/Depr 191.71%
Profit Quality 142.71%
Current Ratio 4.77
Quick Ratio 4.61
Altman-Z 3.12
F-Score6
WACC8.48%
ROIC/WACC1.29
Cap/Depr(3y)209.72%
Cap/Depr(5y)185.98%
Profit Quality(3y)108.64%
Profit Quality(5y)100.73%
Growth
EPS 1Y-17.24%
EPS 3Y17.23%
EPS 5Y-7.23%
EPS growth Q2Q0%
EPS Next Y-26.86%
EPS Next 2Y-27.72%
EPS Next 3Y-19.46%
EPS Next 5Y14.3%
Revenue growth 1Y-20.42%
Revenue growth 3Y8.52%
Revenue growth 5Y5.91%
Revenue growth Q2Q-0.72%
Revenue Next Year-2.95%
Revenue Next 2Y-2.19%
Revenue Next 3Y-2.74%
Revenue Next 5Y6.61%
EBIT growth 1Y-32.53%
EBIT growth 3Y4.18%
EBIT growth 5Y0.02%
EBIT Next Year6.2%
EBIT Next 3Y9.24%
EBIT Next 5Y21.61%
FCF growth 1Y-15.28%
FCF growth 3Y3.63%
FCF growth 5Y-2.07%
OCF growth 1Y1.57%
OCF growth 3Y15.11%
OCF growth 5Y5.96%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA